JKJung A. Kim

Jung A. Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jung A. Kim has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Eun Roh

    Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea

    2 shared publications
  • Hye Jin Yoo

    Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea

    2 shared publications
  • Kyung Mook Choi

    Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea

    2 shared publications
  • Sei Hyun Baik

    Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea

    2 shared publications
  • So-Hyeon Hong

    Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Korea University, Seoul, South Korea

    2 shared publications
  • You-Bin Lee

    Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

    2 shared publications

Latest Publications

  • Ginsenoside Mc1 improves liver steatosis and insulin resistance by attenuating ER stress

    by Eun Roh, Hwan-Jin Hwang, Joo Won Kim, So-Hyeon Hong, Jung A Kim, You-Bin Lee, Kyung Mook Choi, Sei Hyun Baik, Hye Jin Yoo


  • Open Access

    γ-Glutamyltransferase Variability and the Risk of Mortality, Myocardial Infarction, and Stroke: A Nationwide Population-Based Cohort Study

    by Hye Soo Chung, Ji Sung Lee, Jung A. Kim, Eun Roh, You Bin Lee, So Hyeon Hong, Hye Jin Yoo, Sei Hyun Baik, Nan Hee Kim, Ji A Seo, et al.

    Although it has been suggested that the γ-glutamyltransferase (GGT) level is an indicator of cardiometabolic disorders, there is no previous study to evaluate the implication of GGT variability on the development of myocardial infarction (MI), stroke, all-cause mortality, and cardiovascular disease (CVD)-related mortality. GGT variability was measured as the coefficient variance (GGT-CV), standard deviation (GGT-SD), and variability independent of the mean (GGT-VIM). Using the population-based Korean National Health Insurance Service-Health Screening Cohort, we followed 158,736 Korean adults over a median duration of 8.4 years. In multivariable Cox proportional hazard analysis, the risk of mortality, MI, and stroke showed a stepwise increase according to the quartiles of GGT-CV, GGT-SD or GGT-VIM. In the highest quartile of GGT-CV compared to the lowest quartile after adjusting for confounding variables including mean GGT, the hazard ratios (HRs) for incident MI, stroke, mortality, and CVD-related mortality were 1.19 (95% confidence interval (CI), 1.06–1.34; p < 0.001), 1.20 (95% CI, 1.10–1.32; p < 0.001), 1.41 (95% CI, 1.33–1.51; p < 0.001), and 1.52 (95% CI, 1.30–1.78; p < 0.001), respectively, which were similar or even higher compared with those associated with total cholesterol variability. This is the first study to demonstrate that high GGT variability is associated with increased risk of MI, stroke, all-cause mortality, and CVD-related mortality in the general population.